Emmessar Biotech & Nutrition Limited (BOM:524768)
29.43
-1.31 (-4.26%)
At close: Jul 29, 2025
BOM:524768 Revenue
In the fiscal year ending March 31, 2025, Emmessar Biotech & Nutrition had annual revenue of 26.20M INR with 28.31% growth. Emmessar Biotech & Nutrition had revenue of 7.04M in the quarter ending March 31, 2025, with 1,207.81% growth.
Revenue
26.20M
Revenue Growth
+28.31%
P/S Ratio
5.67
Revenue / Employee
1.54M
Employees
17
Market Cap
148.63M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 26.20M | 5.78M | 28.31% |
Mar 31, 2024 | 20.42M | -4.73M | -18.82% |
Mar 31, 2023 | 25.15M | 7.42M | 41.83% |
Mar 31, 2022 | 17.73M | -66.83M | -79.03% |
Mar 31, 2021 | 84.56M | 37.03M | 77.89% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,765.41B |
HDFC Bank | 2,736.06B |
Bharti Airtel | 1,729.85B |
Tata Consultancy Services | 2,561.48B |
ICICI Bank | 2,054.85B |
State Bank of India | 3,429.39B |
Infosys | 1,672.76B |
Hindustan Unilever | 631.21B |